Precision System Science Co., Ltd. (PCNEF)
Precision System Science Co., Ltd. operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Matsudo, JP. The stock last traded at $2.28, up 0.00% on the session, giving a market capitalisation of $62.0M. On trailing twelve-month figures it carries a trailing P/E of 43.81, a net margin of 2.7%. Its beta of 0.38 implies it has historically moved less than the broad market.
Precision System Science Co., Ltd. (PSS), along with its various subsidiaries, specializes in the development, production, and global distribution of advanced technological solutions. Their product portfolio includes automated and physicochemical instruments, specialized software, and other related items, serving both the Japanese domestic market and international clients. The company is also a key manufacturer and supplier of essential plastic consumables designed for use with its automated systems, in addition to offering chemical reagents and sophisticated automated nucleic acid extraction systems. PSS further provides geneLEAD, a dedicated instrument utilized for molecular diagnostics. A significant aspect of the company's operations is its robust commitment to research and development, focusing on the practical application of innovations within the in vitro diagnostics (IVD) sector, particularly for genetic and protein analysis. Established in 1985, Precision System Science Co., Ltd. maintains its headquarters in Matsudo, Japan.
Precision System Science Co., Ltd. is most often compared with the following Healthcare names: